These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 20097480)

  • 1. Metabolic syndrome is a real disease and premalignant state induced by oncogenic stresses to block malignant transformation.
    Erol A
    Med Hypotheses; 2010 Jun; 74(6):1038-43. PubMed ID: 20097480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic DNA damage response and metabolic syndrome as a premalignant state.
    Erol A
    Curr Mol Med; 2010 Apr; 10(3):321-34. PubMed ID: 20334625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidation in the nucleotide pool, the DNA damage response and cellular senescence: Defective bricks build a defective house.
    Rai P
    Mutat Res; 2010 Nov; 703(1):71-81. PubMed ID: 20673809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The causes of cancer revisited: "mitochondrial malignancy" and ROS-induced oncogenic transformation - why mitochondria are targets for cancer therapy.
    Ralph SJ; Rodríguez-Enríquez S; Neuzil J; Saavedra E; Moreno-Sánchez R
    Mol Aspects Med; 2010 Apr; 31(2):145-70. PubMed ID: 20206201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activated oncogenes promote and cooperate with chromosomal instability for neoplastic transformation.
    Woo RA; Poon RY
    Genes Dev; 2004 Jun; 18(11):1317-30. PubMed ID: 15175263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncogene-induced senescence as an initial barrier in lymphoma development.
    Braig M; Lee S; Loddenkemper C; Rudolph C; Peters AH; Schlegelberger B; Stein H; Dörken B; Jenuwein T; Schmitt CA
    Nature; 2005 Aug; 436(7051):660-5. PubMed ID: 16079837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA damage signalling guards against activated oncogenes and tumour progression.
    Bartek J; Bartkova J; Lukas J
    Oncogene; 2007 Dec; 26(56):7773-9. PubMed ID: 18066090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Redox effector factor-1, combined with reactive oxygen species, plays an important role in the transformation of JB6 cells.
    Yang S; Misner BJ; Chiu RJ; Meyskens FL
    Carcinogenesis; 2007 Nov; 28(11):2382-90. PubMed ID: 17566060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cell cycle regulation after exposure to ionizing radiation].
    Teyssier F; Bay JO; Dionet C; Verrelle P
    Bull Cancer; 1999 Apr; 86(4):345-57. PubMed ID: 10341340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 protein or BID protein select the route to either apoptosis (programmed cell death) or to cell cycle arrest opposing carcinogenesis after DNA damage by ROS.
    Wiseman A
    Med Hypotheses; 2006; 67(2):296-9. PubMed ID: 16580789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hallmarks for senescence in carcinogenesis: novel signaling players.
    Caino MC; Meshki J; Kazanietz MG
    Apoptosis; 2009 Apr; 14(4):392-408. PubMed ID: 19169823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell and tissue responses to genotoxic stress.
    Coates PJ; Lorimore SA; Wright EG
    J Pathol; 2005 Jan; 205(2):221-35. PubMed ID: 15643669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints.
    Bartkova J; Rezaei N; Liontos M; Karakaidos P; Kletsas D; Issaeva N; Vassiliou LV; Kolettas E; Niforou K; Zoumpourlis VC; Takaoka M; Nakagawa H; Tort F; Fugger K; Johansson F; Sehested M; Andersen CL; Dyrskjot L; Ørntoft T; Lukas J; Kittas C; Helleday T; Halazonetis TD; Bartek J; Gorgoulis VG
    Nature; 2006 Nov; 444(7119):633-7. PubMed ID: 17136093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis.
    Sarkisian CJ; Keister BA; Stairs DB; Boxer RB; Moody SE; Chodosh LA
    Nat Cell Biol; 2007 May; 9(5):493-505. PubMed ID: 17450133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication.
    Di Micco R; Fumagalli M; Cicalese A; Piccinin S; Gasparini P; Luise C; Schurra C; Garre' M; Nuciforo PG; Bensimon A; Maestro R; Pelicci PG; d'Adda di Fagagna F
    Nature; 2006 Nov; 444(7119):638-42. PubMed ID: 17136094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dinstinct ROS and biochemical profiles in cells undergoing DNA damage-induced senescence and apoptosis.
    Song YS; Lee BY; Hwang ES
    Mech Ageing Dev; 2005 May; 126(5):580-90. PubMed ID: 15811427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumour biology: senescence in premalignant tumours.
    Collado M; Gil J; Efeyan A; Guerra C; Schuhmacher AJ; Barradas M; Benguría A; Zaballos A; Flores JM; Barbacid M; Beach D; Serrano M
    Nature; 2005 Aug; 436(7051):642. PubMed ID: 16079833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of p53 and caspase 3 activity on cell death and senescence in response to methotrexate in the breast tumor cell.
    Hattangadi DK; DeMasters GA; Walker TD; Jones KR; Di X; Newsham IF; Gewirtz DA
    Biochem Pharmacol; 2004 Nov; 68(9):1699-708. PubMed ID: 15450935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of TP53 associated genes in Fanconi anemia cells after mitomycin C and hydroxyurea treatment.
    Martinez A; Hinz JM; Gómez L; Molina B; Acuña H; Jones IM; Frias S; Coleman MA
    Mutat Res; 2008 Oct; 656(1-2):1-7. PubMed ID: 18647660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human cell senescence as a DNA damage response.
    von Zglinicki T; Saretzki G; Ladhoff J; d'Adda di Fagagna F; Jackson SP
    Mech Ageing Dev; 2005 Jan; 126(1):111-7. PubMed ID: 15610769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.